These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 7249502
1. Effect of furosemide in congestive heart failure. Nomura A, Yasuda H, Minami M, Akimoto T, Miyazaki K, Arita T. Clin Pharmacol Ther; 1981 Aug; 30(2):177-82. PubMed ID: 7249502 [Abstract] [Full Text] [Related]
2. Hydralazine and furosemide kinetics. Nomura A, Yasuda H, Katoh K, Akimoto T, Miyazaki K, Arita T. Clin Pharmacol Ther; 1982 Sep; 32(3):303-6. PubMed ID: 7105621 [Abstract] [Full Text] [Related]
3. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. Cohen N, Golik A, Dishi V, Zaidenstein R, Weissgarten J, Averbukh Z, Modai D. Miner Electrolyte Metab; 1996 Sep; 22(4):248-52. PubMed ID: 8807629 [Abstract] [Full Text] [Related]
4. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition. Good JM, Brady AJ, Noormohamed FH, Oakley CM, Cleland JG. Circulation; 1994 Jul; 90(1):220-4. PubMed ID: 8026000 [Abstract] [Full Text] [Related]
5. Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose-Response Curves in Worsening Refractory Congestive Heart Failure. Paterna S, Di Gaudio F, La Rocca V, Balistreri F, Greco M, Torres D, Lupo U, Rizzo G, di Pasquale P, Indelicato S, Cuttitta F, Butler J, Parrinello G. Adv Ther; 2015 Oct; 32(10):971-82. PubMed ID: 26521190 [Abstract] [Full Text] [Related]
6. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. Circulation; 2002 Mar 19; 105(11):1348-53. PubMed ID: 11901047 [Abstract] [Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function. Traeger A, Stein G, Sperschneider H, Keil E. Int J Clin Pharmacol Ther Toxicol; 1984 Sep 19; 22(9):481-6. PubMed ID: 6500766 [Abstract] [Full Text] [Related]
8. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure. Chaturvedi PR, O'Donnell JP, Nicholas JM, Shoenthal DR, Waters DH, Gwilt PR. Int J Clin Pharmacol Ther Toxicol; 1987 Mar 19; 25(3):123-8. PubMed ID: 3557737 [Abstract] [Full Text] [Related]
10. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Dormans TP, Gerlag PG. Eur Heart J; 1996 Dec 06; 17(12):1867-74. PubMed ID: 8960430 [Abstract] [Full Text] [Related]
11. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Pivac N, Rumboldt Z, Sardelić S, Bagatin J, Polić S, Ljutić D, Naranca M, Capkun V. Int J Clin Pharmacol Res; 1998 Dec 06; 18(3):121-8. PubMed ID: 9825268 [Abstract] [Full Text] [Related]
12. Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response. Mulder H, Schopman W, van der Lely AJ, Schopman W. Horm Metab Res; 1987 Feb 06; 19(2):80-3. PubMed ID: 3549504 [Abstract] [Full Text] [Related]
13. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure. Andreasen F, Mikkelsen E. Eur J Clin Pharmacol; 1977 Aug 17; 12(1):15-22. PubMed ID: 902673 [Abstract] [Full Text] [Related]
14. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Clin Pharmacol Ther; 1997 Aug 17; 62(2):187-93. PubMed ID: 9284855 [Abstract] [Full Text] [Related]
15. Determinants of the diuretic response to furosemide in infants with congestive heart failure. Green TP, Mirkin BL. Pediatr Cardiol; 1982 Aug 17; 3(1):47-51. PubMed ID: 7155939 [Abstract] [Full Text] [Related]
16. Combination of furosemide and metolazone in the treatment of severe congestive heart failure. Grosskopf I, Rabinovitz M, Rosenfeld JB. Isr J Med Sci; 1986 Nov 17; 22(11):787-90. PubMed ID: 3793436 [Abstract] [Full Text] [Related]
17. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure]. Wehling M, Zimmermann J, Weil J, Gerzer R, Theisen K. Z Kardiol; 1990 Feb 17; 79(2):120-5. PubMed ID: 2157313 [Abstract] [Full Text] [Related]
18. Different diuretic properties between tolvaptan and furosemide in congestive heart failure patients with diuretic resistance and renal impairment: a subanalysis of the K-STAR. Ikeda Y, Inomata T, Kida K, Shibagaki Y, Sato N, Izumi T, Ako J, Kanagawa Aquaresis Investigators. Heart Vessels; 2019 Mar 17; 34(3):442-451. PubMed ID: 30259172 [Abstract] [Full Text] [Related]
19. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Am Heart J; 2003 Mar 17; 145(3):459-66. PubMed ID: 12660669 [Abstract] [Full Text] [Related]
20. Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. Vargo DL, Brater DC, Rudy DW, Swan SK. J Am Soc Nephrol; 1996 Jul 17; 7(7):1032-7. PubMed ID: 8829118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]